Product nameMycophenolic acid, Inosine monophosphate dehydrogenase inhibitor.
DescriptionImmunosuppressant. Inosine monophosphate dehydrogenase inhibitor.
Biological descriptionPotent inosine monophosphate dehydrogenase inhibitor (IMPDH) (Ki values are 11 and 6 nM at IMPDH type I and II, respectively). Decreases RNA and DNA synthesis. Immunosuppressive agent. Shows antiviral and antitumor effects in vitro and in vivo.
Chemical name(4E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid
Storage instructionsStore at +4°C. Store under desiccating conditions. The product can be stored for up to 12 months.
Solubility overviewSoluble in DMSO to 100 mM
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
- Pathways and Processes
- Metabolic signaling pathways
- Energy transfer pathways
- Energy Metabolism
This product has been referenced in:
- Morath C et al. Antifibrotic actions of mycophenolic acid. Clin Transplant 20 Suppl 17:25-9 (2006). Read more (PubMed: 17100698) »
- Catapano CV et al. GTP depletion induced by IMP dehydrogenase inhibitors blocks RNA-primed DNA synthesis. Mol Pharmacol 47:948-55 (1995). Read more (PubMed: 7746281) »
- Hager PW et al. Recombinant human inosine monophosphate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor binding. Biochem Pharmacol 49:1323-9 (1995). Read more (PubMed: 7763314) »